Eagle Pharmaceuticals Inc. (EGRX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 0 $0 0%
2.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

0 $0 0%
3.
Nantahala Capital ManagementCALL

Wilmot B. Harkey And Daniel Mack

0 $0 0%
4.
PDT Partners

Peter Muller

0 $0 0%
5. 0 $0 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$55.45 350 Officer 700 2017-08-16 Filing
$50.09 1,584 Director 971,000 2017-08-09 Filing
$49.21 15,206 Director 969,416 2017-08-09 Filing
$48.06 3,610 Director 954,210 2017-08-09 Filing
$71.49 350 Officer 350 2017-06-12 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$13.87 10,694 Large Shareholder, Officer, Director 545,447 2023-11-02 Filing
$13.82 10,925 Large Shareholder, Officer, Director 556,141 2023-11-01 Filing
$15.11 710 Large Shareholder, Officer, Director 567,066 2023-10-03 Filing
$14.41 10,024 Large Shareholder, Officer, Director 567,776 2023-10-03 Filing
$15.23 9,511 Large Shareholder, Officer, Director 577,800 2023-10-02 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 23,594 $11,797 0%
2. 12,000 $6,000 0%
3. 3,411 $1,706 0%
4. 105 $391 0%
5. 350 $175 0%
News See All